- $1.42bn
- $11.05bn
- $1.76bn
- 43
- 84
- 65
- 69
2022 January 1st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS/A | PROSPECTUS/A | PROSPECTUS/A |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 829 | 981 | 1,761 |
Cost of Revenue | |||
Gross Profit | 487 | 470 | 588 |
Selling / General / Administrative Expenses | |||
Depreciation and Amortization | |||
Unusual Expense / Income | |||
Other Operating Expenses | |||
Total Operating Expenses | 783 | 1,055 | 2,158 |
Operating Profit | 45.5 | -74.3 | -397 |
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | 69.9 | 122 | 197 |
Provision for Income Taxes | |||
Net Income After Taxes | 56.5 | 98.2 | 141 |
Net Income Before Extraordinary Items | |||
Net Income | 56.5 | 98.2 | 141 |
Adjustments to Net Income | |||
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | 56.5 | 91.6 | 128 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | 0.798 | 1.09 | 1.97 |
Dividends per Share |